Abacus Life (ABL) said late Thursday it priced an underwritten public offering of 12.5 million common shares at $8 apiece.
The company is offering 10 million shares, with the rest to be sold by certain stockholders. It also granted underwriters a 30-day option to purchase up to an additional 1.5 million shares from the company and up to 375,000 more shares from the selling stockholders.
The offering is expected to close on Nov. 25.
Abacus said gross proceeds are expected to be about $100 million, excluding the underwriters' option to purchase additional shares.
The company plans to use the proceeds for its operations, including the purchase of life settlement policies, among other things.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.